The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 71 through 80 of 202 results (Download Results)

Show results per page

COvid-19 Vaccines Booster in Immunocompromised Rheumatic Diseases (COVBIRD)

Fortin, Paul R | Université Laval | Operating Grant | $995,312

CIHR Quebec 2021

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection

Yao, Xiao-Jian | University of Manitoba | Operating Grant | $50,000

CIHR Manitoba 2021

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

Archambault, Patrick | Université Laval | Operating Grant | $499,945

CIHR Quebec 2021

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Liang, Chen | Lady Davis Institute for Medical Research | Operating Grant | $50,000

CIHR Quebec 2021

Transdiagnostic internet cognitive-behavior therapy for mixed anxiety and depressive disorders in primary care: A dissemination and implementation study

Roberge, Pasquale | Université de Sherbrooke | Operating Grant | $200,000

CIHR Quebec 2020

Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.

Su, Ruey-Chyi | University of Manitoba | Operating Grant | $431,000

CIHR Manitoba 2021

A pragmatic randomized controlled trial of a CKD specific telemonitoring platform to minimize adverse outcomes in high risk CKD patients.

Rigatto, Claudio | University of Manitoba | Project Grant | $562,275

CIHR Manitoba 2021

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Moitessier, Nicolas R | McGill University | Operating Grant | $50,000

CIHR Quebec 2021

A behavioural science approach to evaluate the prevalence and predictors of COVID-19-related mental health issues and maladaptive behavioural coping (MBC) to inform the development of strategies for tailored interventions

Bacon, Simon L | CIUSSS du Nord-de-l'Ile-de Montréal - Hôpital Sacré Coeur | Operating Grant | $200,000

CIHR Quebec 2020

Mental Health, Substance Use, and Service Needs, Access, and Delivery among Two-Spirit, Gay, Bisexual, Queer, and Other Men Who Have Sex with Men in Manitoba

Souleymanov, Roustam | University of Manitoba | Operating Grant | $175,000

CIHR Manitoba 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COvid-19 Vaccines Booster in Immunocompromised Rheumatic Diseases (COVBIRD)

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

COVID-19 Variant Supplement – Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses

Transdiagnostic internet cognitive-behavior therapy for mixed anxiety and depressive disorders in primary care: A dissemination and implementation study

Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.

A pragmatic randomized controlled trial of a CKD specific telemonitoring platform to minimize adverse outcomes in high risk CKD patients.

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

A behavioural science approach to evaluate the prevalence and predictors of COVID-19-related mental health issues and maladaptive behavioural coping (MBC) to inform the development of strategies for tailored interventions

Mental Health, Substance Use, and Service Needs, Access, and Delivery among Two-Spirit, Gay, Bisexual, Queer, and Other Men Who Have Sex with Men in Manitoba